Thrivent Financial for Lutherans’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-14,962
Closed -$2.65M 2335
2020
Q1
$2.65M Hold
14,962
0.01% 837
2019
Q4
$2.86M Buy
14,962
+64
+0.4% +$11.5K 0.01% 876
2019
Q3
$2.51M Buy
14,898
+947
+7% +$154K 0.01% 888
2019
Q2
$2.34M Sell
13,951
-114
-0.8% -$15.8K 0.01% 915
2019
Q1
$2.06M Sell
14,065
-9,538
-40% -$1.38M 0.01% 947
2018
Q4
$3.15M Buy
23,603
+9,787
+71% +$1.6M 0.01% 719
2018
Q3
$2.63M Sell
13,816
-421
-3% -$77.3K 0.01% 802
2018
Q2
$2.37M Buy
14,237
+358
+3% +$57.5K 0.01% 838
2018
Q1
$2.34M Buy
13,879
+412
+3% +$69.1K 0.01% 844
2017
Q4
$2.2M Sell
13,467
-71
-0.5% -$12.7K 0.01% 877
2017
Q3
$2.77M Buy
13,538
+780
+6% +$181K 0.01% 770
2017
Q2
$3.1M Sell
12,758
-516,678
-98% -$121M 0.01% 708
2017
Q1
$126M Sell
529,436
-182,570
-26% -$42.5M 0.55% 37
2016
Q4
$150M Buy
712,006
+4,653
+0.7% +$964K 0.67% 27
2016
Q3
$163M Sell
707,353
-45,070
-6% -$11M 0.74% 19
2016
Q2
$174M Buy
752,423
+17,725
+2% +$4.09M 0.83% 19
2016
Q1
$197M Buy
734,698
+100,698
+16% +$28.8M 0.95% 16
2015
Q4
$198M Sell
634,000
-37,826
-6% -$11.3M 0.95% 13
2015
Q3
$183M Buy
671,826
+93,835
+16% +$28.8M 0.96% 11
2015
Q2
$175M Buy
577,991
+23,340
+4% +$6.96M 0.97% 14
2015
Q1
$165M Sell
554,651
-46,364
-8% -$13.2M 0.91% 17
2014
Q4
$155M Buy
601,015
+84,016
+16% +$21M 0.86% 20
2014
Q3
$125M Buy
516,999
+428,586
+485% +$95.9M 0.72% 31
2014
Q2
$19.7M Sell
88,413
-800
-0.9% -$166K 0.11% 198
2014
Q1
$18.4M Buy
89,213
+110
+0.1% +$21.8K 0.11% 195
2013
Q4
$15M Sell
89,103
-1,000
-1% -$156K 0.09% 239
2013
Q3
$13M Buy
90,103
+3,300
+4% +$440K 0.08% 262
2013
Q2
$11K Buy
+86,803
New +$9.83M 0.07% 288

Other funds holding AGN

Thrivent Financial for Lutherans's AGN Position: Q2 2020 in Review

Thrivent Financial for Lutherans sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 14,962 shares — an estimated $2.65M sold.

Thrivent Financial for Lutherans first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $198M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Thrivent Financial for Lutherans reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Thrivent Financial for Lutherans sold 14,962 Allergan plc shares in Q2 2020, an estimated $2.65M.
  • Thrivent Financial for Lutherans first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • Thrivent Financial for Lutherans's Allergan plc position peaked at $198M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Thrivent Financial for Lutherans's 13F filing for Q2 2020, filed 12 Aug 2020.